Identifying Substance Use Consequences
Part of paid clinical trials in Belmont, Massachusetts.
- Sponsor
- Mclean Hospital
- Study ID
- NCT07503067
- Status
- Recruiting
Conditions
- Substance Use Disorder (SUD)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- none, there is no intervention in this study — OTHERthis is not an intervention study
Study Details
The goal of this study is to develop a new tool for measuring substance use disorder treatment outcome. We will start by interviewing people and gathering advisory groups to develop the items for this new tool.
Key Dates
- Start date
- Feb 10, 2026
- Status verified
- Mar 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: substance use disorderpeople with lived experience with substance use disorder, a family member of someone with a substance use disorder or clinical provider treating substance use disorders
Primary Outcome Measure
Extracted Themes [ Time Frame: same-day, single session ]
Central Contacts
- R. Kathryn McHugh, PhD617-855-2000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| McLean Hospital | Belmont | Massachusetts | 02478 |
Find similar trials in Belmont, MA
By research site
Related Studies
- Pathways to Perinatal Mental Health EquityRecruiting · University of Massachusetts, Worcester · Shrewsbury, Massachusetts
- Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject DrugsPHASE4 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- Open-Label Psilocybin Study in Transdiagnostic PopulationPHASE1 · Recruiting · Yale University · New Haven, Connecticut
- Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.EARLY_PHASE1 · Recruiting · Medical College of Wisconsin · Milwaukee, Wisconsin